ELRIG survey exposes the conference paradox: companies invest heavily to acquire customers but fail to prepare for impact.
You're spending tens of thousands on conference booths to acquire new customers. But are you actually ready to win them?
Matt Wilkinson and Jasmine Gruia-Gray surveyed 107 exhibitors at ELRIG Drug Discovery 2025 and discovered a disturbing pattern: companies are acquisition-focused yet preparation-poor. While 61% struggle with lead quality, only 14% have competitive battle cards ready. Worse still, most exhibitors couldn't articulate what makes them memorable, had no strategic conversation frameworks, and were improvising competitor responses on the fly.
This isn't about budget constraints—it's about strategic negligence. Companies are treating conferences as lead-scanning exercises rather than architecting experiences that convert prospects into pipeline. The "rinse and repeat" approach is failing, and hope is not a commercial plan.
What you will learn:
Keywords: life science marketing, conference strategy, ELRIG Drug Discovery, competitive preparation, battle cards, memorable differentiation, strategic booth conversations, acquisition strategy, life science tools, trade show ROI, conference planning, customer acquisition
Ready to stop wasting your conference investment? Preparation determines whether you're memorable or invisible among 200 booths. Subscribe for more unvarnished life science marketing insights, and visit strivenn.com to access our AI Readiness Diagnostic.